AIM-HI launched the Women’s Venture Competition in 2020, despite the global pandemic. Since then, the Women’s Venture Competition has been empowering female scientist-entrepreneurs in the oncology arena. Through this annual competition, AIM-HI provides critically needed seed funding, important coaching, and continuous access to our global network to highly promising female scientist-entrepreneurs, thus empowering women in oncology and furthering the development of groundbreaking treatments.
Launched in 2019, the BRACE Award was developed by our Hong Kong-based partner organization, the Asian Fund for Cancer Research (AFCR). AIM-HI is now collaborating with AFCR to identify and invest in innovative oncology start-ups that can make an impact for cancers prevent in underserved populations.
Benefits of participating in the competition include:
- Interacting with and receiving valuable feedback from the selection and judging committee members, who are key opinion leaders in the oncology field.
- Top finalists will be awarded honorariums, recognized with certificates, and considered for further investment, subject to rigorous due diligence conducted by our Investment Committee.
- The finalist who passes the due diligence process will be eligible to receive investment from AIM-HI and co-investors; the process itself will also help the company assess and refine its IP and strategy, clinical development plan, and position itself well for other investors.
- The winners will gain recognition and presentation opportunities within the oncology research community, facilitating networking and collaboration opportunities with global cancer experts and investors.
Together, we can make the next generation of cancer treatments a reality.